SYMBOL: BLUW
Company: Blue Water Acquisition Corp.
Company: Blue Water Acquisition Corp.
SYMBOL
: BLUWStage: 2. Seeking Target
Size: $73.319.399
Latest Price: $10,12
Previous close: $10,07
All time high price: $10,67
Volume: 408
Average volume: 12.088
FOLLOW SPAC
DISCOVER NEW FRIENDS
GET AHEAD OF THE GAME
Blue Water Acquisition Corp. is listed on the stock exchange with the ticker / Symbol BLUW,
BLUW SPAC all time high was $10,67 and the lowest price in the last 52 week was: ,
the current BLUW stock price is $10,12. BLUW has an overall market cap of: $73.319.399.
The latest volume was: 408.
BLUW is currently in stage: 2. Seeking Target.
You can read all about BLUW and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about BLUW and Blue Water Acquisition Corp.? Join us today.
BLUW SPAC all time high was $10,67 and the lowest price in the last 52 week was: ,
the current BLUW stock price is $10,12. BLUW has an overall market cap of: $73.319.399.
The latest volume was: 408.
BLUW is currently in stage: 2. Seeking Target.
You can read all about BLUW and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about BLUW and Blue Water Acquisition Corp.? Join us today.
- Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast Cancer – PRNewswire
- Two Big SPAC Deals (SRNG, AURC) After Monday's Mess – TheStreet
- Will Honest's IPO Take More Shine Off SPACs? – TheStreet
- What's Next for SPACs – TheStreet
- Tech Sell Off will Hit SPAC Stocks Hard – TheStreet
- SPAC Ideas for Tuesday – TheStreet
- Ucloudlink Extends Australian Footprint With Intercel Partnership – Benzinga
- SPAC Hall Of Famer Betsy Cohen To Appear On 'SPACs Attack': Numerous Deals Completed And More To Come – Benzinga
- Neuralink Co-Founder Max Hodak Departs The Elon Musk Company Onward To 'New Things' – Benzinga
- Denali-Biogen Parkinson's Disease Candidate Shows Reductions In Biomarkers; Late Study To Begin By 2021 End – Benzinga
- Adverum's Wet AMD Gene Therapy Shows Long Term Benefit In Treatment-Experienced Patients – Benzinga
- Merger Arbitrage Mondays – Standard Industries Finally Bags W. R. Grace – Seeking Alpha
- ON Semiconductor Shares Are Trading Higher On Q1 Earnings Beat, Better Than Expected Q2 Guidance – Benzinga
- Novartis' Beovu Non-Inferior To Aflibercept In Phase 3 Diabetic Macular Edema Study – Benzinga
- Gogo Rolls Out Unlimited Business Aviation Streaming, Data Plan – Benzinga
